1-palmitoyl-lysophosphatidic acid has been researched along with calcimycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lapetina, EG; Watson, SP; Wolf, M | 1 |
| Gerrard, JM; Robinson, P | 1 |
2 other study(ies) available for 1-palmitoyl-lysophosphatidic acid and calcimycin
| Article | Year |
|---|---|
The formation of [3H]inositol phosphates in human platelets by palmitoyl lysophosphatidic acid is blocked by indomethacin.
Topics: Blood Platelets; Calcimycin; Calcium; Cyclooxygenase Inhibitors; Diglycerides; Enzyme Activation; Humans; Indomethacin; Inositol Phosphates; Lysophospholipids; Phosphatidic Acids; Phosphorylation; Platelet Aggregation; Sugar Phosphates; Type C Phospholipases | 1985 |
Lysophosphatidic acid can activate platelets without increasing 32P-labelling of phosphatidic acid.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Blood Platelets; Calcimycin; Humans; Kinetics; Lysophospholipids; Phosphatidic Acids; Phosphorus Radioisotopes; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Thrombin | 1984 |